GT Medical Technologies’ implant delivers radiation therapy directly to the bed of an excised brain tumor—a potential game-changer for people with highly proliferative, hard-to-treat tumors such as glioblastomas. Its GammaTile Therapy is now in use at 75 US hospitals and the firm has raised $26 million over the past three years—not bad for a company that launched its flagship product at the height of the pandemic.
GT Medical announced the first participant enrolled in the GammaTile Enhanced Stupp ALTernative (GESTALT) trial. While this trial is still in its infancy, if the results are favorable, it may influence protocols for treating glioblastomas (GBMs) and bridge the gap between surgery and chemoradiation.
Enrolling Newly Diagnosed Patients with Glioblastoma in the GESTALT Clinical Trial
Doctors at UofL Health are the first in the state to use a new brain cancer radiation treatment called the gamma tile.
GT Medical Technologies’ GammaTile is a surgically targeted radiation therapy (STaRT) for brain tumors. GT Medical Technologies designed the GammaTile to provide immediate, dose-intense treatment at the completion of resection. The company says the therapy system can extend local recurrence-free survival with minimal complications to reduce patient burden and assure compliance.
Kettering Health is now the first provider in the Dayton area to offer GammaTile Therapy.
Today is Glioblastoma Awareness Day
Posted at 5:54 PM, Jul 20, 2022 and last updated 5:54 PM, Jul 20, 2022
Today is Glioblastoma Awareness Day, a day to help those affected by this devastating disease and remember lives lost to Glioblastoma (GMB), lives like Senator John McCain, and Mike Traphagen.
For his invention of GammaTile® Therapy used to treat operable brain tumors, David Brachman, M.D. is the 2022 winner of the Mensa Foundation’s Copper Black Award for Creative Achievement.
Tampa General Hospital and USF Health Morsani College of Medicine physicians are the first in Hillsborough County to bring patients experiencing recurring brain tumors a groundbreaking treatment.
GT Medical Technologies announced today that it has earned the International Organization for Standardization (ISO) 13485:2016 certification from GMED. The certification demonstrates the company’s compliance with medical device quality management system requirements under the Medical Device Single Audit Program (MDSAP).